MYCOPATHOLOGIA

Scope & Guideline

Driving innovation in mycology and plant science.

Introduction

Explore the comprehensive scope of MYCOPATHOLOGIA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore MYCOPATHOLOGIA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0301-486x
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1938 to 1941, 1943, from 1949 to 1950, from 1959 to 1962, from 1974 to 2024
AbbreviationMYCOPATHOLOGIA / Mycopathologia
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'MYCOPATHOLOGIA' focuses on the study of fungal diseases, their epidemiology, diagnosis, treatment, and the underlying mechanisms of pathogenicity. It serves as a platform for researchers and clinicians to share significant findings in the field of mycology, with an emphasis on both clinical and environmental aspects of fungal infections.
  1. Clinical Mycology:
    This area encompasses research related to the diagnosis, treatment, and management of fungal infections in humans, including emerging and drug-resistant pathogens.
  2. Molecular and Genomic Studies:
    Research focusing on the genetic and molecular characteristics of fungi, including their resistance mechanisms, which aids in understanding pathogenicity and developing targeted treatments.
  3. Epidemiology and Public Health:
    Studies that investigate the distribution, determinants, and control of fungal diseases, particularly in vulnerable populations and in relation to global health crises.
  4. Innovative Diagnostic Techniques:
    Development and evaluation of new diagnostic methods, such as metagenomics, next-generation sequencing, and immunological assays, to improve detection and management of fungal infections.
  5. Environmental Mycology:
    Exploration of fungal flora in various environments, their interactions with hosts, and their roles in health and disease, especially in relation to climate change and ecological impacts.
  6. Therapeutic Strategies:
    Research on antifungal treatments, including novel agents and combination therapies, aimed at overcoming resistance and improving patient outcomes.
The journal 'MYCOPATHOLOGIA' has seen an evolution in its themes, reflecting current challenges in fungal research and clinical practice. Emerging trends indicate a shift towards more integrated and innovative approaches in the study of mycoses.
  1. COVID-19-Associated Fungal Infections:
    Research on fungal infections linked to COVID-19, such as mucormycosis and aspergillosis, has surged, highlighting the impact of the pandemic on fungal disease epidemiology and management.
  2. Antifungal Resistance Mechanisms:
    A growing body of work is focused on understanding the mechanisms of antifungal resistance in various pathogens, contributing to the development of new treatment strategies.
  3. Metagenomic and Next-Generation Sequencing Applications:
    The application of advanced sequencing technologies for the diagnosis of fungal infections is becoming increasingly prominent, allowing for more precise and comprehensive pathogen identification.
  4. Fungal Co-infections in Immunocompromised Patients:
    There is an increasing emphasis on studying fungal co-infections in patients with underlying conditions, such as HIV/AIDS and cancer, especially in relation to treatment outcomes.
  5. Environmental and Climate Impact on Fungal Diseases:
    Research is emerging around the influence of environmental changes and climate on fungal disease patterns, which is critical for public health planning and response.
  6. Pediatric Fungal Infections:
    The focus on fungal infections in pediatric populations is increasing, addressing unique challenges in diagnosis and treatment in this vulnerable group.

Declining or Waning

While 'MYCOPATHOLOGIA' continues to cover a broad range of topics in mycology, certain areas of research have seen a decline in focus. This may reflect changing priorities in the field or a shift towards more pressing issues related to fungal infections.
  1. Traditional Mycological Techniques:
    There has been a noticeable decline in studies focusing solely on classical culture methods for fungal identification, as molecular techniques become more prevalent and preferred.
  2. Non-invasive Diagnostic Approaches:
    Research on older non-invasive diagnostic methods is diminishing, likely due to the growing emphasis on more accurate and rapid molecular diagnostics.
  3. Fungal Diseases in Non-Human Hosts:
    While still relevant, there appears to be a waning interest in researching fungal infections primarily affecting non-human hosts, potentially overshadowed by the human health focus.
  4. Historical Perspectives on Fungal Infections:
    Papers that provide retrospective analyses or historical data seem to be decreasing, possibly as the field moves towards contemporary issues and emerging pathogens.
  5. Basic Research on Fungal Biology:
    There is a reduced emphasis on fundamental studies of fungal biology and ecology that do not directly relate to human health impacts or clinical applications.

Similar Journals

IMA Fungus

Empowering Scientific Collaboration in Fungal Research.
Publisher: BMCISSN: 2210-6340Frequency: 1 issue/year

IMA Fungus is an esteemed open-access journal published by BMC, dedicated to advancing research in the fields of fungi, plant sciences, and ecological systems. With an ISSN of 2210-6340 and E-ISSN 2210-6359, this journal has been an influential platform since its inception in 2010, contributing significantly to the scientific community in the United States and beyond. The journal’s remarkable impact can be seen in its Q1 quartile rankings across multiple categories, including Agricultural and Biological Sciences, Ecology, Evolution, Behavior and Systematics, and Plant Science, positioning it among the top literary sources in these fields. Notably, IMA Fungus holds impressive Scopus rankings, with the Agricultural and Biological Sciences category placing it in the 98th percentile, evidencing its crucial role in disseminating impactful research. Given its commitment to fostering accessibility and collaboration, IMA Fungus continues to be an invaluable resource for researchers, professionals, and students aiming to explore and understand the complex roles of fungi within various ecosystems.

CURRENT OPINION IN INFECTIOUS DISEASES

Fostering Critical Discussions in Infectious Disease Trends
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0951-7375Frequency: 6 issues/year

CURRENT OPINION IN INFECTIOUS DISEASES, published by Lippincott Williams & Wilkins, is a premier journal that focuses on the latest developments and understanding in the field of infectious diseases. With its ISSN 0951-7375 and E-ISSN 1473-6527, this journal has gained recognition for its pivotal role in advancing knowledge from 1988 to its current publications in 2024. Boasting an impressive Q1 ranking in both Infectious Diseases and the Medical Microbiology category, it holds a reputable position among the top journals in the field. The journal serves as an essential resource for researchers, professionals, and students alike, providing them with timely reviews, analyses, and perspectives that shape contemporary practice and policy. While lacking open access options, it ensures a critical examination of emerging trends and unique insights that foster informed discussions. With its consistently high impact factor, CURRENT OPINION IN INFECTIOUS DISEASES remains a vital platform for thought leaders and innovators navigating the complexities of infectious disease research.

MYCOTAXON

Pioneering Research in Fungal Systematics
Publisher: MYCOTAXON LTDISSN: 0093-4666Frequency: 4 issues/year

MYCOTAXON is a peer-reviewed journal dedicated to the field of mycology, focusing on the taxonomy, systematics, and ecology of fungi. Published by MYCOTAXON LTD, this journal plays a crucial role in advancing our understanding of fungal biodiversity and its significance within various ecosystems. Although it currently does not offer open access options, its contributions are vital to the scientific community, especially with its established presence since 1989. With an HIndex reflecting its relevance and attracting a dedicated readership, MYCOTAXON is recognized within the Q4 quartile in both Ecology, Evolution, Behavior, and Systematics, and Plant Science categories as of 2023. This places it among a critical cohort of journals that contribute to the understanding of ecological dynamics and plant-fungal interactions. Researchers, professionals, and students can benefit from the insights provided in MYCOTAXON, making it an indispensable resource for anyone involved in the study of fungi.

Pathologia

Fostering Collaborative Discoveries in Health Sciences
Publisher: ZAPORIZHZHYA STATE MEDICAL UNIVISSN: 2306-8027Frequency: 3 issues/year

Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

MYCOLOGIA

Leading the way in interdisciplinary fungal studies.
Publisher: TAYLOR & FRANCIS INCISSN: 0027-5514Frequency: 6 issues/year

MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.

NEW ZEALAND JOURNAL OF BOTANY

Cultivating Insights into New Zealand's Unique Flora
Publisher: TAYLOR & FRANCIS LTDISSN: 0028-825XFrequency: 4 issues/year

The New Zealand Journal of Botany, published by the esteemed Taylor & Francis Ltd, serves as a pivotal platform for disseminating significant research in the fields of Ecology, Evolution, Behavior and Systematics, as well as Plant Science. With a rich history dating back to 1963 and an impressive convergence extending to 2024, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the complexities of plant life and ecological systems in New Zealand and beyond. The journal is currently categorized in the Q3 quartile for both relevant disciplines as of 2023, reflecting its balanced influence within the global academic community. Although not an open access journal, it retains a significant impact factor, evidenced by its Scopus rankings, which place it within the top half of its categories. This makes it an invaluable tool for students, researchers, and academics aiming to engage with robust, peer-reviewed scientific findings and contribute to the evolving discourse surrounding botany and ecological research.

MYCOLOGICAL PROGRESS

Advancing fungal research for a sustainable future.
Publisher: SPRINGER HEIDELBERGISSN: 1617-416XFrequency: 4 issues/year

MYCOLOGICAL PROGRESS, published by SPRINGER HEIDELBERG, is an esteemed journal dedicated to advancing the field of mycology and associated biological disciplines. With an ISSN of 1617-416X and an E-ISSN of 1861-8952, this journal has established itself as a leading source of high-quality research, evidenced by its impressive rankings in the Q1 quartile across various categories such as Agricultural and Biological Sciences, Ecology, and Plant Science. As of 2023, MYCOLOGICAL PROGRESS ranks 37 out of 193 in Agricultural and Biological Sciences (miscellaneous) and 183 out of 721 in Ecology, demonstrating its significant impact in the ecosystem of scientific literature. This journal not only aims to disseminate innovative research findings but also strives to foster interdisciplinary collaboration among scientists, ecologists, and agriculturists around the globe. While retaining a traditional model of publication, MYCOLOGICAL PROGRESS remains crucial for those seeking to deepen their understanding of fungal biology and its broader environmental implications.

Fungal Biology

Championing Interdisciplinary Approaches in Mycology
Publisher: ELSEVIER SCI LTDISSN: 1878-6146Frequency: 12 issues/year

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

Medical Mycology Journal

Bridging Research and Practice in Medical Mycology
Publisher: JAPANESE SOC MEDICAL MYCOLOGYISSN: 2185-6486Frequency: 4 issues/year

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

RESEARCH IN MICROBIOLOGY

Fostering innovation in microbiology for a global audience.
Publisher: ELSEVIERISSN: 0923-2508Frequency: 8 issues/year

Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.